Background and Aims: Most of the pure glass nodules (GGNs) ≤10 mm in diameter on computed tomography (CT) are considered as non-invasive adenocarcinoma. However, some of them are invasive adenocarcinomas (IAs). These cases should be treated differently in terms of surgery because they have different prognosis. Therefore, it is necessary to study the predictive factors for IA when pure GGN 10 mm or less in diameter is present.
≤10 mm in diameter on computed tomography (CT) are considered as non-invasive adenocarcinoma. However, some of them are invasive adenocarcinomas (IAs). These cases should be treated differently in terms of surgery because they have different prognosis. Therefore, it is necessary to study the predictive factors for IA when pure GGN 10 mm or less in diameter is present.
Methods: A retrospective study was conducted on the clinical data of 2261 patients with lung cancer who underwent surgical resection. We selected 450 patients of lung adenocarcinoma with pure ground-glass nodules 10 mm or less in diameter. We compared the clinical, surgical, and pathological characteristics of non-IA with those of IA.
Results: Among the 450 patients, 14 (3.11%) were AAH, 228 (50.67%) were AIS, 182 (40.04%) were MIA, 26 (5.78%)were IA. The age of the IA was older than the non-IA (60.19 vs 51.37 years; P < 0.001). The mean axial diameter of the GGN lesions in IA was larger than that in non-IA (8.02 vs 7.46 mm; P = 0.043). The mean density of CT value in IA was higher than that in non-IA (−514.15 vs-606.24 HU; P < 0.01). The IA had more EGFR mutation than non-IA (58.8% vs 29.7%; P = 0.02). Univariate logistic regression analysis identified the ag, unsmooth margin, axial size and mean density, EGFR mutation of GGNs as predictive factors for IA. Multivariate logistic regression analysis identified the age, unsmooth margin, axial size and mean density of GGNs as predictive factors for IA.
Conclusion:
The differences between IA and non-IA in age, lesion size, mean density and margin was significant. 
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Results:
The results were obtained samples of 30 patients of 10 patients who refused chemotherapy (treatment group) and 20 patients undergoing chemotherapy (control group).the incidence of lung cancer is related to the age of 75% in patients aged >40 years, while 15% of cases aged <40 years, on the response of the subjective test Chi-square, the chemotherapy patients gained significant value in the variable ECOG P <0,05 (P = 0.00) and chest pain P < 0.05 (P = 0.004) which shows both variables showed significant differences, whereas the treatment group gained significant value in the variable ECOG P < 0.05 (P = 0.00), chest pain P < 0.05 (P = 0.00) and vomiting P < 0.05 (P = 0.02) of the three variables showed significant differences. The Mann-Whitney test results obtained P < 0.05 (P = 0.00) showed that the difference in the results of MSCT scan thorax treatment group and control group. Methods: A single-center, case series study was conducted. NSCLC patients treated with atezolizumab from April to May 2018 were entered in the study. Patient characteristics, response rate, and adverse events were retrospectively analyzed.
Results: 14 patients in total were reviewed. Average age of patients was 70. AE .4 years. Histological types were eight patients (57.1%) had adenocarcinoma, four patients (28.6%) had squamous, one patient (7.1%) had adenosquamous, and one (7.1%) had NOS histological type. All patients had received one or more previous therapies (median, 3) before treatment with atezolizumab. Nine patients (64.3%) were previously treated with one or more anti-programmed cell death 1 (PD-1) antibodies. Immunohistochemical analysis showed that four (28.6%), three 
